कृपया अन्य खोज का प्रयास करें
Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company’s HER-Vaxx is in phase 2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling and is in phase I trial; and CF33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. The company has a collaboration with Arovella Therapeutics Ltd to test the integration of Arovella's CAR19- iNKT cell therapy with the onCARlytics platform, as well as a research collaboration with RenovoRx, Inc. to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. Imugene Limited was incorporated in 1986 and is based in Sydney, Australia.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Paul Edward-Alexander Hopper | 67 | 2012 | Executive Chairman |
Jens W. Eckstein | - | 2019 | Independent Non-Executive Director |
Yuman Fong | - | 2019 | Chair of Oncolytic Virotherapy Scientific Advisory Board |
Leslie Chong | - | 2015 | CEO, MD & Executive Director |
Ursula Wiedermann | - | 2015 | Member of Scientific Advisory Board |
Neil H. Segal | - | 2014 | Member of Scientific Advisory Board |
Peter Schmid | - | 2017 | Member of Scientific Advisory Board |
Pravin T. P. Kaumaya | - | 2018 | Member of Scientific Advisory Board |
Tanios Bekaii-Saab | - | 2018 | Member of Scientific Advisory Board |
Josep Tabernero | - | 2018 | Member of Scientific Advisory Board |
Kimberlee Cobleigh Drapkin | 55 | 2023 | Non-Executive Director |
Yanghee Woo | - | 2022 | Member of Scientific Advisory Board |
Prasad S. Adusumilli | - | 2019 | Member of Scientific Advisory Board |
Yelena Y. Janjigian | - | 2016 | Scientific Advisory Board Member |
Saul J. Priceman | - | - | Member of Oncolytics Virotherapy Scientific Advisory Board |
Lesley Russell | 62 | 2019 | Independent Non-Executive Director |
Jakob Dupont | 58 | 2022 | Non-Executive Director |
Rebecca Auer | - | - | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है